SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-201401
Filing Date
2022-07-26
Accepted
2022-07-26 06:10:04
Documents
15
Period of Report
2022-07-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d352859d8k.htm   iXBRL 8-K 23943
2 EX-99.1 d352859dex991.htm EX-99.1 42793
6 GRAPHIC g352859g0725172058753.jpg GRAPHIC 2327
7 GRAPHIC g352859g0725172058974.jpg GRAPHIC 3036
  Complete submission text file 0001193125-22-201401.txt   206211

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20220726.xsd EX-101.SCH 2882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20220726_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20220726_pre.xml EX-101.PRE 10830
9 EXTRACTED XBRL INSTANCE DOCUMENT d352859d8k_htm.xml XML 3203
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 221104832
SIC: 2836 Biological Products, (No Diagnostic Substances)